{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:37:51Z","timestamp":1794411471019,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","award":["MAN-Q1\/Q2"],"award-info":[{"award-number":["MAN-Q1\/Q2"]}],"id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","award":["2016MayPR734"],"award-info":[{"award-number":["2016MayPR734"]}],"id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MRC-MR\/P000096\/1"],"award-info":[{"award-number":["MRC-MR\/P000096\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dissemination of tumour cells to the bone marrow is an early event in breast cancer, however cells may lie dormant for many years before bone metastases develop. Treatment for bone metastases is not curative, therefore new adjuvant therapies which prevent the colonisation of disseminated cells into metastatic lesions are required. There is evidence that cancer stem cells (CSCs) within breast tumours are capable of metastasis, but the mechanism by which these colonise bone is unknown. Here, we establish that bone marrow-derived IL1\u03b2 stimulates breast cancer cell colonisation in the bone by inducing intracellular NFkB and CREB signalling in breast cancer cells, leading to autocrine Wnt signalling and CSC colony formation. Importantly, we show that inhibition of this pathway prevents both CSC colony formation in the bone environment, and bone metastasis. These findings establish that targeting IL1\u03b2-NFKB\/CREB-Wnt signalling should be considered for adjuvant therapy to prevent breast cancer bone metastasis.<\/jats:p>","DOI":"10.1038\/s41467-019-12807-0","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T12:38:37Z","timestamp":1572611917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Microenvironmental IL1\u03b2 promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling"],"prefix":"10.1038","volume":"10","author":[{"given":"Rachel","family":"Eyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-4823","authenticated-orcid":false,"given":"Denis G.","family":"Alf\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-2669","authenticated-orcid":false,"given":"Ang\u00e9lica","family":"Santiago-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-2070","authenticated-orcid":false,"given":"Claire","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-6657","authenticated-orcid":false,"given":"Bruno M.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lefley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6614-9735","authenticated-orcid":false,"given":"Joanna","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1322-4671","authenticated-orcid":false,"given":"Mick","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-6515","authenticated-orcid":false,"given":"Sacha J.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-3665","authenticated-orcid":false,"given":"Andrew H.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Farnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4826-0771","authenticated-orcid":false,"given":"Penelope D.","family":"Ottewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-3123","authenticated-orcid":false,"given":"Robert B.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"12807_CR1","unstructured":"International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx (2012)."},{"key":"12807_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y Husemann","year":"2008","unstructured":"Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58\u201368 (2008).","journal-title":"Cancer Cell"},{"issue":"7634","key":"12807_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"Hedayatollah Hosseini","year":"2016","unstructured":"Hosseini, H. et al. Early dissemination seeds metastasis in breast cancer. Nature, https:\/\/doi.org\/10.1038\/nature20785 (2016).","journal-title":"Nature"},{"key":"12807_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun, S. et al. A pooled analysis of bone marrow micrometastasis in breast cancer. New Engl. J. Med. 353, 793\u2013802 (2005).","journal-title":"New Engl. J. Med."},{"key":"12807_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrc3910","volume":"15","author":"CM Ghajar","year":"2015","unstructured":"Ghajar, C. M. Metastasis prevention by targeting the dormant niche. Nat. Rev. Cancer 15, 238\u2013247 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"12807_CR6","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists' Collaborative, G.","year":"2005","unstructured":"Early Breast Cancer Trialists' Collaborative, G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687\u20131717 (2005).","journal-title":"Lancet"},{"key":"12807_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nature15260","volume":"526","author":"DA Lawson","year":"2015","unstructured":"Lawson, D. A. et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526, 131\u2013135 (2015).","journal-title":"Nature"},{"key":"12807_CR8","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","volume":"12","author":"M Balic","year":"2006","unstructured":"Balic, M. et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res. 12, 5615\u20135621 (2006).","journal-title":"Clin. Cancer Res."},{"key":"12807_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jnci\/83.2.119","volume":"83","author":"MR Bani","year":"1991","unstructured":"Bani, M. R., Garofalo, A., Scanziani, E. & Giavazzi, R. Effect of interleukin-1-beta on metastasis formation in different tumor systems. J. Natl. Cancer Inst. 83, 119\u2013123 (1991).","journal-title":"J. Natl. Cancer Inst."},{"key":"12807_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"SB Coffelt","year":"2015","unstructured":"Coffelt, S. B. et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345\u2013348 (2015).","journal-title":"Nature"},{"key":"12807_CR11","doi-asserted-by":"publisher","unstructured":"Holen, I. et al. IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget, https:\/\/doi.org\/10.18632\/oncotarget.12289 (2016).","DOI":"10.18632\/oncotarget.12289"},{"key":"12807_CR12","doi-asserted-by":"crossref","unstructured":"Tulotta, C. et al. Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078\u20130432.CCR-18\u20132202 (2019).","DOI":"10.1158\/1078-0432.CCR-18-2202"},{"key":"12807_CR13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"12807_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.1061803","volume":"17","author":"G Dontu","year":"2003","unstructured":"Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells. Genes Dev. 17, 1253\u20131270 (2003).","journal-title":"Genes Dev."},{"key":"12807_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10911-012-9255-3","volume":"17","author":"FL Shaw","year":"2012","unstructured":"Shaw, F. L. et al. A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J. Mammary Gland Biol. Neoplasia 17, 111\u2013117 (2012).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"12807_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/ERC-13-0158","volume":"21","author":"F Nutter","year":"2014","unstructured":"Nutter, F. et al. Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line. Endocr.-Relat. Cancer 21, 327\u2013341 (2014).","journal-title":"Endocr.-Relat. Cancer"},{"key":"12807_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","volume":"69","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302\u20131313 (2009).","journal-title":"Cancer Res."},{"issue":"7","key":"12807_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/cancers8070060","volume":"8","author":"Felipe de Sousa e Melo","year":"2016","unstructured":"de Sousa, E. M. F. & Vermeulen, L. Wnt Signaling in Cancer Stem Cell Biology. Cancers 8, https:\/\/doi.org\/10.3390\/cancers8070060 (2016).","journal-title":"Cancers"},{"key":"12807_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"I Malanchi","year":"2012","unstructured":"Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85\u201389 (2012).","journal-title":"Nature"},{"key":"12807_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/dev.01117","volume":"131","author":"X He","year":"2004","unstructured":"He, X., Semenov, M., Tamai, K. & Zeng, X. LDL receptor-related proteins 5 and 6 in Wnt\/beta-catenin signaling: arrows point the way. Development 131, 1663\u20131677 (2004).","journal-title":"Development"},{"key":"12807_CR21","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","volume":"109","author":"A Gurney","year":"2012","unstructured":"Gurney, A. et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc. Natl Acad. Sci. USA 109, 11717\u201311722 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12807_CR22","doi-asserted-by":"publisher","first-page":"e9370","DOI":"10.1371\/journal.pone.0009370","volume":"5","author":"C Fuerer","year":"2010","unstructured":"Fuerer, C. & Nusse, R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS ONE 5, e9370 (2010).","journal-title":"PLoS ONE"},{"key":"12807_CR23","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc. Natl Acad. Sci. USA 110, 20224\u201320229 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12807_CR24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C Wahl","year":"1998","unstructured":"Wahl, C., Liptay, S., Adler, G. & Schmid, R. M. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Investig. 101, 1163\u20131174 (1998).","journal-title":"J. Clin. Investig."},{"key":"12807_CR25","doi-asserted-by":"publisher","first-page":"17622","DOI":"10.1073\/pnas.0406374101","volume":"101","author":"JL Best","year":"2004","unstructured":"Best, J. L. et al. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc. Natl Acad. Sci. USA 101, 17622\u201317627 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12807_CR26","doi-asserted-by":"crossref","unstructured":"Eyre, R. et al. Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis. J. Mammary Gland Biol. Neoplasia, https:\/\/doi.org\/10.1007\/s10911\u2013016\u20139361\u20138 (2016).","DOI":"10.1007\/s10911-016-9361-8"},{"key":"12807_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu, S. et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2, 78\u201391 (2014).","journal-title":"Stem Cell Rep."},{"key":"12807_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10549-015-3352-0","volume":"150","author":"CD Savci-Heijink","year":"2015","unstructured":"Savci-Heijink, C. D. et al. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res. Treat. 150, 547\u2013557 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"12807_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41556-018-0173-5","volume":"20","author":"Z Castano","year":"2018","unstructured":"Castano, Z. et al. IL-1beta inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat. Cell Biol. 20, 1084\u20131097 (2018).","journal-title":"Nat. Cell Biol."},{"key":"12807_CR30","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","volume":"129","author":"CEM de Mooij","year":"2017","unstructured":"de Mooij, C. E. M., Netea, M. G., van der Velden, W. & Blijlevens, N. M. A. Targeting the interleukin-1 pathway in patients with hematological disorders. Blood 129, 3155\u20133164 (2017).","journal-title":"Blood"},{"key":"12807_CR31","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","volume":"18","author":"A Carey","year":"2017","unstructured":"Carey, A. et al. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. Cell Rep. 18, 3204\u20133218 (2017).","journal-title":"Cell Rep."},{"key":"12807_CR32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","volume":"177","author":"N Baryawno","year":"2019","unstructured":"Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915\u20131932 e1916 (2019).","journal-title":"Cell"},{"key":"12807_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","volume":"572","author":"MD Wellenstein","year":"2019","unstructured":"Wellenstein, M. D. et al. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature 572, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"12807_CR34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens, M. & Singh, J. A. Anakinra for rheumatoid arthritis: a systematic review. J. Rheumatol. 36, 1118\u20131125 (2009).","journal-title":"J. Rheumatol."},{"key":"12807_CR35","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto, N. et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. New Engl. J. Med. 367, 2396\u20132406 (2012).","journal-title":"New Engl. J. Med."},{"key":"12807_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto, N. et al. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheumatism 64, 557\u2013567 (2012).","journal-title":"Arthritis Rheumatism"},{"key":"12807_CR37","unstructured":"ClinicalTrials.gov. A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands, <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01351103> (2016)."},{"key":"12807_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","volume":"15","author":"JT Erler","year":"2009","unstructured":"Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35\u201344 (2009).","journal-title":"Cancer Cell"},{"key":"12807_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012).","journal-title":"Nat. Med."},{"key":"12807_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov, I. et al. Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc. Natl Acad. Sci. USA 116, 1361\u20131369 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12807_CR41","doi-asserted-by":"crossref","unstructured":"Coutinho, L. H., Gilleece, M. H., de Wynter, E., Will, A. & Testa, N. G. in Haemopoiesis: A Practical Approach\u00a0(eds Testa, N. G. & Molineux, G.) 75\u2013100 (Oxford University Press, 1993).","DOI":"10.1093\/oso\/9780199633661.003.0005"},{"key":"12807_CR42","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gng015","volume":"31","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).","journal-title":"Nucleic Acids Res."},{"key":"12807_CR43","doi-asserted-by":"publisher","first-page":"18115","DOI":"10.1073\/pnas.1006732107","volume":"107","author":"H Liu","year":"2010","unstructured":"Liu, H. et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc. Natl Acad. Sci. USA 107, 18115\u201318120 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12807_CR44","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","volume":"20","author":"PD Ottewell","year":"2014","unstructured":"Ottewell, P. D. et al. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo. Clin. Cancer Res. 20, 2922\u20132932 (2014).","journal-title":"Clin. Cancer Res."},{"key":"12807_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524 (2005).","journal-title":"Nature"},{"key":"12807_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005\u20131009 (2009).","journal-title":"Nature"},{"key":"12807_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671\u2013679 (2005).","journal-title":"Lancet"},{"key":"12807_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"12807_CR49","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/onc.2012.196","volume":"32","author":"S Moleirinho","year":"2013","unstructured":"Moleirinho, S. et al. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene 32, 1821\u20131830 (2013).","journal-title":"Oncogene"},{"key":"12807_CR50","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/bioinformatics\/btg202","volume":"19","author":"D Rajagopalan","year":"2003","unstructured":"Rajagopalan, D. A comparison of statistical methods for analysis of high density oligonucleotide array data. Bioinformatics 19, 1469\u20131476 (2003).","journal-title":"Bioinformatics"},{"key":"12807_CR51","unstructured":"Therneau, T. A Package for Survival Analysis in S. version 2.38, https:\/\/CRAN.R-project.org\/package=survival. (2005)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12807-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T03:20:57Z","timestamp":1721964057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12807-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12807"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12807-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G. is Chief Scientific Officer at Oncomed Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5016"}}